Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae.

Singh-Babak SD, Shekhar T, Smith AM, Giaever G, Nislow C, Cowen LE.

Mol Biosyst. 2012 Oct;8(10):2575-84. doi: 10.1039/c2mb25107h.

PMID:
22751784
2.

The pleitropic drug ABC transporters from Saccharomyces cerevisiae.

Rogers B, Decottignies A, Kolaczkowski M, Carvajal E, Balzi E, Goffeau A.

J Mol Microbiol Biotechnol. 2001 Apr;3(2):207-14. Review.

PMID:
11321575
3.

Chemical-genetic approaches for exploring the mode of action of natural products.

Lopez A, Parsons AB, Nislow C, Giaever G, Boone C.

Prog Drug Res. 2008;66:237, 239-71. Review.

PMID:
18416308
4.

Role of micafungin in the antifungal armamentarium.

Ikeda F, Tanaka S, Ohki H, Matsumoto S, Maki K, Katashima M, Barrett D, Aoki Y.

Curr Med Chem. 2007;14(11):1263-75. Review.

PMID:
17504145
5.

Yeast multidrug resistance: the PDR network.

Balzi E, Goffeau A.

J Bioenerg Biomembr. 1995 Feb;27(1):71-6. Review.

PMID:
7629054
6.

[The fungal cell wall and the mechanism of action of anidulafungin].

Pontón J.

Rev Iberoam Micol. 2008 Jun;25(2):78-82. Review. Spanish.

7.

Cell wall construction in Saccharomyces cerevisiae.

Klis FM, Boorsma A, De Groot PW.

Yeast. 2006 Feb;23(3):185-202. Review.

8.

[The mechanisms of resistance to echinocandin class of antifungal drugs].

Niimi K, Niimi M.

Nihon Ishinkin Gakkai Zasshi. 2009;50(2):57-66. Review. Japanese.

9.

[In vitro antifungal activity of micafungin].

Quindós G, Eraso E, Javier Carrillo-Muñoz A, Cantón E, Pemán J.

Rev Iberoam Micol. 2009 Mar 31;26(1):35-41. doi: 10.1016/S1130-1406(09)70006-3. Epub 2009 May 7. Review. Spanish.

10.

Antibiotics that inhibit fungal cell wall development.

Debono M, Gordee RS.

Annu Rev Microbiol. 1994;48:471-97. Review.

PMID:
7826015
11.

Signaling cascades as drug targets in model and pathogenic fungi.

Bastidas RJ, Reedy JL, Morales-Johansson H, Heitman J, Cardenas ME.

Curr Opin Investig Drugs. 2008 Aug;9(8):856-64. Review.

12.

Calcineurin-mediated regulation of hyphal growth, septation, and virulence in Aspergillus fumigatus.

Juvvadi PR, Lamoth F, Steinbach WJ.

Mycopathologia. 2014 Dec;178(5-6):341-8. doi: 10.1007/s11046-014-9794-9. Epub 2014 Aug 15. Review.

13.

A survey of yeast genomic assays for drug and target discovery.

Smith AM, Ammar R, Nislow C, Giaever G.

Pharmacol Ther. 2010 Aug;127(2):156-64. doi: 10.1016/j.pharmthera.2010.04.012. Epub 2010 May 28. Review.

14.

Activation of stress signalling pathways enhances tolerance of fungi to chemical fungicides and antifungal proteins.

Hayes BM, Anderson MA, Traven A, van der Weerden NL, Bleackley MR.

Cell Mol Life Sci. 2014 Jul;71(14):2651-66. doi: 10.1007/s00018-014-1573-8. Epub 2014 Feb 14. Review.

PMID:
24526056
15.

A spoke in the wheel: calcium spikes disrupt yeast cell cycle.

Zhang YQ, Rao R.

Cell Cycle. 2008 Apr 1;7(7):870-3. Epub 2008 Jan 14. Review.

PMID:
18414024
16.

The yeast cell-wall salvage pathway.

Popolo L, Gualtieri T, Ragni E.

Med Mycol. 2001;39 Suppl 1:111-21. Review.

PMID:
11800265
17.

Multi-level response of the yeast genome to glucose.

Geladé R, Van de Velde S, Van Dijck P, Thevelein JM.

Genome Biol. 2003;4(11):233. Epub 2003 Oct 15. Review.

18.

Acidic calcium stores of Saccharomyces cerevisiae.

Cunningham KW.

Cell Calcium. 2011 Aug;50(2):129-38. doi: 10.1016/j.ceca.2011.01.010. Epub 2011 Mar 5. Review.

19.

Yeast: a microbe with macro-implications to antimicrobial drug discovery.

Balibar CJ, Roemer T.

Brief Funct Genomics. 2016 Mar;15(2):147-54. doi: 10.1093/bfgp/elv038. Epub 2015 Oct 5. Review.

PMID:
26443612
20.

Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.

Cardenas ME, Cruz MC, Del Poeta M, Chung N, Perfect JR, Heitman J.

Clin Microbiol Rev. 1999 Oct;12(4):583-611. Review.

Supplemental Content

Support Center